Financial Advisors, LLC Merck & Co., Inc. Transaction History

Financial Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$100.18 - $109.02 $193,447 - $210,517	1,931 New	1,931 $210,000
Q2 2023 Aug 01, 2023	SELL	$108.61 - $118.38 $2,715 - $2,959	-25 Reduced 0.91%	2,731 $315,000
Q1 2023 May 04, 2023	SELL	$102.94 - $114.86 $9,264 - $10,337	-90 Reduced 3.16%	2,756 $293,000
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $17,488 - $22,422	-200 Reduced 6.57%	2,846 $315,000
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $3,888 - $4,368	-46 Reduced 1.49%	3,046 $275,000
Q1 2022 May 12, 2022	SELL	$73.51 - $82.4 $30,065 - $33,701	-409 Reduced 11.68%	3,092 $254,000
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $11,131 - $13,943	154 Added 4.6%	3,501 $268,000
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $843 - $933	12 Added 0.36%	3,347 $260,000
Q1 2021 Apr 16, 2021	BUY	$68.86 - $81.11 $6,059 - $7,137	88 Added 2.71%	3,335 $257,000
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $233,037 - $258,623	3,247 New	3,247 $266,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Financial Advisors, LLC with notifications on news.